Commodore Capital LP Genocea Biosciences, Inc. Transaction History

Commodore Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.01 - $1.38 $30,797 - $4.25 Million	-3,079,756 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.74 - $2.33 $261,537 - $350,219	150,309 Added 5.13%	3,079,756 $5.91 Million
Q2 2021 Aug 16, 2021	BUY	$2.06 - $2.82 $119,115 - $163,060	57,823 Added 2.01%	2,929,447 $6.86 Million
Q1 2021 May 17, 2021	BUY	$2.35 - $4.01 $2.6 Million - $4.43 Million	1,105,723 Added 62.62%	2,871,624 $7.78 Million
Q4 2020 Feb 16, 2021	BUY	$1.91 - $2.67 $3.37 Million - $4.71 Million	1,765,901 New	1,765,901 $4.27 Million

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Commodore Capital LP, based on Form 13F filings with the SEC.

Stay updated on Commodore Capital LP with notifications on news.